Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Clinical trial NCT07249905 · RECRUITING

Trial details

NCT number: NCT07249905
Sponsor: ModeX Therapeutics, An OPKO Health Company
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma Waldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma PMBCL HGBCL FL Lymphoma Lymphoplasmacytic Lymphoma Follicular Lymphoma (FL)

Start date: 2026-04-13
Primary completion: 2028-01-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.